Short description
BioMark Diagnostics is an oncology-focused company.
Description
BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites.
They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals to help commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards..
Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Richmond, Quebec, Canada, North America
Founded on
January 1, 2006
Exited on
November 7, 2014
Went public on
November 7, 2014
Stock symbol
BUX
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Noaccessforu, Cannot Access, Blurry Noaccess, Noaccess, Noaccess, Uh Ohhhh
Sign in for full access
Founders
Rashid Ahmed Bux